Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer

NCT01912443 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT01912443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01912443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer
Lead sponsor
Sun Yat-sen University
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2013
Completion date
Not reported
Enrollment
600 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer